136 related articles for article (PubMed ID: 36733054)
21. A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.
Kim KM; Yoon DH; Lee SG; Lim SN; Sug LJ; Huh J; Suh C
J Korean Med Sci; 2009 Jun; 24(3):525-8. PubMed ID: 19543522
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma.
Takahashi H; Sano T; Kawamura S; Sano K; Miyasaka R; Yamazaki T; Sakakibara M; Abe T; Hashimoto K; Nagaoka M; Kamata M; Naito S; Aoyama T; Moriya R; Takeuchi Y
CEN Case Rep; 2022 May; 11(2):184-190. PubMed ID: 34569002
[TBL] [Abstract][Full Text] [Related]
23. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
24. [Retroperitoneal Malignant Lymphoma: A Case Report].
Kawamura T; Moriguchi M; Konari S; Murai K; Kato Y; Obara W
Hinyokika Kiyo; 2023 Jan; 69(1):13-17. PubMed ID: 36727456
[TBL] [Abstract][Full Text] [Related]
25. A rare involvement of diffuse large B-cell lymphoma: Peritoneal lymphomatosis with a peritoneal super-scan appearance on
Yılmaz F; Önner H
Hell J Nucl Med; 2022; 25(1):103-105. PubMed ID: 35388807
[TBL] [Abstract][Full Text] [Related]
26. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
27. Primary diffuse large B-cell lymphoma in the maxilla: A case report.
Zou H; Yang H; Zou Y; Lei L; Song L
Medicine (Baltimore); 2018 May; 97(20):e10707. PubMed ID: 29768336
[TBL] [Abstract][Full Text] [Related]
28. Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva.
Harada N; Tagami M; Koh H; Ohsawa M; Hino M; Nakamae H
Int J Hematol; 2021 Oct; 114(4):413-414. PubMed ID: 34424492
[No Abstract] [Full Text] [Related]
29. Diagnostic laparoscopy in a HIV positive patient with disseminated non-Hodgkin's lymphoma.
Antinori A; La Greca A; Crucitti A; Ottou SV; Giustacchini P; Magistrelli P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):177-9. PubMed ID: 16767927
[TBL] [Abstract][Full Text] [Related]
30. [Successful treatment with preceding low-intensity chemotherapy in a primary mediastinal large B cell lymphoma patient diagnosed at 11 weeks of pregnancy].
Hattori D; Yahagi Y; Uryu H; Hosoba R; Momoki M; Nagao R; Yamazaki H
Rinsho Ketsueki; 2019; 60(2):112-117. PubMed ID: 30842377
[TBL] [Abstract][Full Text] [Related]
31. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients.
Tai WM; Quah D; Yap SP; Tan SH; Tang T; Tay KW; Koo YX; Tao M; Quek R; Lim ST
Leuk Lymphoma; 2011 Apr; 52(4):604-12. PubMed ID: 21261504
[TBL] [Abstract][Full Text] [Related]
32. The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
Choi JH; Lim I; Byun BH; Kim BI; Choi CW; Kang HJ; Shin DY; Lim SM
PLoS One; 2022; 17(9):e0273839. PubMed ID: 36156599
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Vassilakopoulos TP; Papageorgiou SG; Angelopoulou MK; Chatziioannou S; Prassopoulos V; Karakatsanis S; Arapaki M; Mellios Z; Sachanas S; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Hatzimichael E; Kotsopoulou M; Dimou M; Variamis E; Boutsis D; Terpos E; Michali E; Karianakis G; Tsirkinidis P; Vadikolia C; Poziopoulos C; Pigaditou A; Vrakidou E; Siakantaris MP; Kyrtsonis MC; Symeonidis A; Anargyrou K; Papaioannou M; Chatziharissi E; Vervessou E; Tsirogianni M; Palassopoulou M; Gainaru G; Mainta C; Tsirigotis P; Assimakopoulou T; Konstantinidou P; Papadaki H; Dimopoulos MA; Pappa V; Karmiris T; Roussou P; Datseris I; Panayiotidis P; Konstantopoulos K; Pangalis GA; Rondogianni P
Ann Hematol; 2021 Sep; 100(9):2279-2292. PubMed ID: 33523289
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
Takahashi T; Minato M; Tsukuda H; Yoshimoto M; Tsujisaki M
Intern Med; 2008; 47(10):975-9. PubMed ID: 18480585
[TBL] [Abstract][Full Text] [Related]
35. Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report.
Tekinalp A; Kars TU; Dikici HZ; Yılmaz PD; Demircioğlu S; Çeneli Ö
J Oncol Pharm Pract; 2022 Mar; 28(2):449-452. PubMed ID: 34549658
[TBL] [Abstract][Full Text] [Related]
36. [Non-Hodgkin lymphoma of the mandible--a case report with differential diagnostic considerations].
Heuberger BM; Weiler D; Bussmann C; Kuttenberger JJ
Schweiz Monatsschr Zahnmed; 2011; 121(5):449-60. PubMed ID: 21656387
[TBL] [Abstract][Full Text] [Related]
37. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
[TBL] [Abstract][Full Text] [Related]
39. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
40. Primary pulmonary diffuse large B-cell lymphoma with multiple ground-glass nodules as the primary manifestation: A case report.
Wang Q; Yan H; Wang R; Li C; Li W; Xu Y; Su Z; Zhang J
Medicine (Baltimore); 2020 Dec; 99(50):e23501. PubMed ID: 33327289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]